<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-770
Date of Submission: 2024-09-27

This report was submitted by a Pharmacist from Collins, Vaughn and Johnson Medical Center concerning patient ANON-PX-6722. The subject is a 58-year-old other with a significant medical history including migraines, seasonal allergies, chronic kidney disease. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin (Anticonvulsant) administered via the Intravenous route at a dosage of 7mg, initiated on 2024-07-10 for Neuropathic pain with the course ongoing.

On approximately 2024-07-11, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Nausea, Diarrhea, Headache. The Nausea was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed agree and advised modern. The current patient status regarding this symptom is 'Recovered'. The Diarrhea was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Headache was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Anyone our fight film. Hope morning leader physical imagine hundred increase. Call poor attack. Quality fight yard happy.</data>
report_id: ADR-2024-770
report_date: '2024-09-27'
patient_details:
  patient_id: ANON-PX-6722
  gender: Other
  relevant_history:
  - migraines
  - seasonal allergies
  - chronic kidney disease
  age_at_reaction: 58
suspected_drugs:
- drug_name: Gabapentin
  dosage: 7mg
  route_of_administration: Intravenous
  start_date: '2024-07-10'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
adverse_reactions:
- symptom_name: Nausea
  onset_date: '2024-07-11'
  severity: Life-threatening
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed agree and advised modern.
- symptom_name: Diarrhea
  onset_date: '2024-07-11'
  severity: Severe
  outcome: Recovered
  intervention_required: false
- symptom_name: Headache
  onset_date: '2024-07-11'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
reporting_facility: Collins, Vaughn and Johnson Medical Center
reporter_type: Pharmacist
notes: Anyone our fight film. Hope morning leader physical imagine hundred increase.
  Call poor attack. Quality fight yard happy.
